Celcuity Inc

CELCNASDAQ · USD
82.58USD0.00 (-0.15%)
1110

Celcuity Inc (CELC) Straddle

CELC straddle scan found 136 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 58.6%.

Read more

Trading a CELC straddle lets you take a pure volatility position on Celcuity Inc without committing to a direction. Celcuity Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate CELC straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on CELC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Celcuity Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the CELC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer.

The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the CELC straddle is the cleanest expression of that view. Our scanner prices every CELC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a CELC straddle into a catalyst or short a CELC straddle to harvest decay, the options straddle setups that matter are all in one place.

Jan 21, 2028220.00$136.4049914%58.6%$356.40$83.600
Jan 21, 2028210.00$127.1049914%58.4%$337.10$82.900
Jan 21, 2028200.00$119.1049914%57.4%$319.10$80.900
Jan 21, 2028195.00$114.5049914%57.4%$309.50$80.500
Jan 21, 2028190.00$110.7549914%56.7%$300.75$79.250
Jan 21, 2028180.00$101.9549914%56.4%$281.95$78.050
Jan 21, 2028185.00$106.6549914%56.4%$291.65$78.350
Jan 21, 2028175.00$99.0049914%55.3%$274.00$76.000
Jan 15, 2027165.00$76.2312814%54.4%$241.23$88.780
Jan 21, 2028170.00$95.7549914%54.3%$265.75$74.250

As of September 16, 2026

Find the right straddle before volatility moves

Track CELC straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial